Results 31 to 40 of about 120,713 (70)

Signaling Networks Regulating Metastatic Progression in Triple-Negative Breast Cancer. [PDF]

Cells
Senkowska Z, Owczarek K, Niewinna K, Lewandowska U.   +3 more
europepmc   +1 more source

Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Pina MA, Ozyurt R, Mao W, Yang H, Santiago-O'Farrill JM, Lu Z, Bast RC.   +6 more
europepmc   +1 more source

Lines Left Uncrossed: The Cost of Attrition in Metastatic Triple Negative Breast Cancer. [PDF]

Cureus
Devi R N, Krishnan M P A, Shenoy PK, Menon A.   +3 more
europepmc   +1 more source

DUSP1: Triple-Negative Breast Cancer and Therapeutic Potential. [PDF]

Curr Oncol
Niture S, Thotala D, Jaboin J, Seneviratne D.   +3 more
europepmc   +1 more source

Immunotherapy Approaches for the Treatment of Triple-Negative Breast Cancer. [PDF]

Cancers (Basel)
Alharbi S, Qasem FF, Talebi MT, Omran NE, Hamoudi R, Harati R.   +5 more
europepmc   +1 more source

Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer. [PDF]

Genome Biol
Lee DK, Kim MH, Hwang Y, Kim SG, Ryu WJ, Kim GU, Yun HM, Park S, Lee JD, Han HJ, Kim GM, Kim KH, Park JB, Kim MJ, Koo JS, Kim JY, Park HS, Kim SI, Gee HY, Park S, Sohn J.   +20 more
europepmc   +1 more source

Selenium-Containing 1,4-Naphthoquinone Derivatives Trigger Reactive Oxygen Species and Apoptosis in Triple-Negative Breast Cancer Cells. [PDF]

Drug Dev Res
Angulo-Elizari E, Raza A, Johnson H, Martínez-Sáez N, Encío I, Sharma AK, Sanmartín C, Plano D.   +7 more
europepmc   +1 more source

Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer. [PDF]

Acta Pharm Sin B
Liang SH.
europepmc   +1 more source

TFF1-mediated suppression of the TCA cycle promotes bone metastasis in triple-negative breast cancer. [PDF]

Transl Oncol
Chen H, Xu Y, Liu Y, Tang Y, Qiu J, Lei L, Lin P, Chen Y, Wu X.   +8 more
europepmc   +1 more source